HIND - ReShape Lifesciences Inc.
2.26
-0.090 -3.982%
Share volume: 24,962
Last Updated: 04-21-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.35
-0.09
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-20-2025 | 08-14-2025 | 11-14-2025 | 03-18-2026 | |
| Assets | ||||||||
| Total Assets | 8.231 M | 6.393 M | 5.615 M | 6.483 M | 9.028 M | 7.045 M | 6.497 M | |
| Current Assets | 7.895 M | 6.087 M | 5.338 M | 6.295 M | 8.862 M | 6.037 M | 5.438 M | |
| Inventories | 3.467 M | 3.246 M | 2.934 M | 2.532 M | 2.552 M | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 92.394 K | 119.301 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 1.380 M | 0.000 | 0.000 | |
| Current Cash | 2.379 M | 1.053 M | 743.000 K | 2.515 M | 4.123 M | 5.707 M | 4.982 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 54.000 K | 48.000 K | 43.000 K | 34.000 K | 30.000 K | 50.168 K | 46.393 K | |
| Other Assets | 282.000 K | 258.000 K | 234.000 K | 154.000 K | 136.000 K | 957.971 K | 1.012 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 8.231 M | 6.393 M | 5.615 M | 6.483 M | 9.028 M | 7.045 M | 6.497 M | |
| Total liabilities | 3.697 M | 3.358 M | 4.128 M | 5.253 M | 3.199 M | 3.127 M | 2.735 M | |
| Total current liabilities | 3.519 M | 3.201 M | 4.025 M | 4.123 M | 3.199 M | 3.119 M | 2.735 M | |
| Accounts Payable | 1.314 M | 1.030 M | 2.105 M | 1.686 M | 1.346 M | 1.904 M | 1.287 M | |
| Other liabilities | 178.000 K | 157.000 K | 103.000 K | 1.130 M | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 178.000 K | 157.000 K | 103.000 K | 1.130 M | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.534 M | 3.035 M | 1.487 M | 1.230 M | 5.829 M | 2.530 M | 2.442 M | |
| Common stock | 642.397 M | 642.486 M | 642.518 M | 642.570 M | 649.798 M | 88.936 M | 90.084 M | |
| Retained earnings | -637.767 M | -639.362 M | -640.943 M | -641.230 M | -643.860 M | -86.338 M | -87.564 M |